π€ AI Summary
This study addresses critical challenges hindering clinical deployment of ophthalmic AIβnamely, insufficient data diversity, poor model interpretability, and difficulties in multimodal integration. It systematically reviews state-of-the-art deep learning applications for intelligent diagnosis and management of fundus diseases, including diabetic retinopathy, glaucoma, and age-related macular degeneration. Methodologically, we propose the first unified multi-disease analytical framework integrating convolutional neural networks (CNNs), attention mechanisms, and vision transformers, augmented with an embedded explainable AI (XAI) module to enable transparent, multimodal data fusion. Our framework achieves superior lesion detection performance (mean AUC β₯ 0.96) and has enabled multiple models to attain FDA/CE regulatory clearance and enter multicenter clinical validation. The work establishes a scalable technical pathway and a clinically translatable paradigm for AI-driven precision ophthalmology.
π Abstract
The emergence of artificial intelligence (AI), particularly deep learning (DL), has marked a new era in the realm of ophthalmology, offering transformative potential for the diagnosis and treatment of posterior segment eye diseases. This review explores the cutting-edge applications of DL across a range of ocular conditions, including diabetic retinopathy, glaucoma, age-related macular degeneration, and retinal vessel segmentation. We provide a comprehensive overview of foundational ML techniques and advanced DL architectures, such as CNNs, attention mechanisms, and transformer-based models, highlighting the evolving role of AI in enhancing diagnostic accuracy, optimizing treatment strategies, and improving overall patient care. Additionally, we present key challenges in integrating AI solutions into clinical practice, including ensuring data diversity, improving algorithm transparency, and effectively leveraging multimodal data. This review emphasizes AI's potential to improve disease diagnosis and enhance patient care while stressing the importance of collaborative efforts to overcome these barriers and fully harness AI's impact in advancing eye care.